Regulatory & Legal

As the AI skills gap widens, a new framework aims to move companies from pilot purgatory to true adoption by training everyone, not just tech experts.

After a costly restatement process, Next Bridge Hydrocarbons shifts its drilling focus. But can a new strategy resolve its unique shareholder crisis?

GWI's new AI award signals a major shift. Discover how AI is reshaping the water sector and which companies are poised to lead this tech-driven transformation.

A hedge fund's disclosure reveals a puzzling short position and a fresh stock purchase in American Axle, hinting at a high-stakes arbitrage play.

A regulatory filing uncovers a major bank's intricate derivatives strategy in a £2.3bn takeover, raising questions about market transparency.

A regulatory filing reveals a key investor's move in the Avadel bidding war, exposing the intense M&A hunger driving the future of health tech.

A major hedge fund's move in a $2.4B semiconductor deal reveals a critical truth: the future of precision medicine is built on high-speed data infrastructure.

A UK regulatory filing reveals a hedge fund's bet against Qualcomm, questioning its major takeover and highlighting the surprising global reach of financial oversight.

From a Greenland mine to a Romanian refinery, a tech breakthrough is de-risking a vital new source of rare earths for the West's defense and green tech.

Hong Kong's JM Group raised $15M in a wild NYSE debut. We look past the volatility to see what this IPO reveals about global supply chains and risk.

Hedge fund Balyasny reveals a 1.26% economic stake in Just Group via derivatives, shining a light on the complex strategies at play in its takeover.

Cemtrex secures $2M for acquisitions, but a 15% stock drop and massive shareholder dilution reveal the high price of its ambitious growth strategy.

After years of delays, River Rock Capital Partners has taken over a stalled NC project, betting on unmet demand in one of the state's fastest-growing areas.

In a market tired of hype, investors are rewarding verifiable results. We explore the tech delivering hard proof, from quantum security to cancer therapies.

A new class of AI-driven blood tests can detect lung cancer recurrence years before imaging, shaking up patient care and the multi-billion dollar diagnostics market.

A potential $39M deal with Luminia positions NeoVolta to move from residential rooftops to utility-scale power, reshaping California's energy future.

S&P Global's latest report confirms Fluence's top-three status in the BESS market, driven by strategic execution and the surging demand for grid stability.

MMTEC dodged delisting, but a one-year Nasdaq monitor and a history of reverse splits raise questions about its long-term viability on US exchanges.

As quantum threats loom, SEALSQ's strategic entry into medical chips with post-quantum cryptography could redefine data security and the industry's supply chain.

Adagio Medical lands ex-Medtronic exec Sean Salmon. His mission: drive its novel cryoablation tech to disrupt the competitive cardiac arrhythmia market.